{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T21:42:56Z","timestamp":1780609376536,"version":"3.54.1"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T00:00:00Z","timestamp":1747526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006469","name":"Fundo para o Desenvolvimento das Ci\u00eancias e da Tecnologia","doi-asserted-by":"publisher","award":["0011\/2023\/AKP"],"award-info":[{"award-number":["0011\/2023\/AKP"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006469","name":"Fundo para o Desenvolvimento das Ci\u00eancias e da Tecnologia","doi-asserted-by":"publisher","award":["0098\/2024\/RIA2"],"award-info":[{"award-number":["0098\/2024\/RIA2"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515012181"],"award-info":[{"award-number":["2024A1515012181"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32071452"],"award-info":[{"award-number":["32071452"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770173"],"award-info":[{"award-number":["81770173"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015260","name":"Macau University of Science and Technology","doi-asserted-by":"publisher","award":["FRG-25-034-PRMRC"],"award-info":[{"award-number":["FRG-25-034-PRMRC"]}],"id":[{"id":"10.13039\/501100015260","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["2023A04J1477"],"award-info":[{"award-number":["2023A04J1477"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021177","name":"Shenzhen Bay Laboratory","doi-asserted-by":"publisher","award":["SZBL2020090501003"],"award-info":[{"award-number":["SZBL2020090501003"]}],"id":[{"id":"10.13039\/501100021177","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jare.2025.05.038","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T11:28:53Z","timestamp":1747826933000},"page":"487-501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Dynamic heterogeneity towards drug resistance in AML cells is primarily driven by epigenomic mechanism unveiled by multi-omics analysis"],"prefix":"10.1016","volume":"80","author":[{"given":"Yulong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyao","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zebin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianwei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjian","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinbin","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanying","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingguang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanchuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6231-3035","authenticated-orcid":false,"given":"Paul K.H.","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7421-8155","authenticated-orcid":false,"given":"Xinghua","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jare.2025.05.038_b0005","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","article-title":"Acute myeloid leukemia","volume":"373","author":"D\u00f6hner","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jare.2025.05.038_b0010","doi-asserted-by":"crossref","unstructured":"Bispo JAB, Pinheiro PS, Kobetz EK: Epidemiology and etiology of leukemia and lymphoma. Cold Spring Harbor perspectives in medicine 2020, 10(6).","DOI":"10.1101\/cshperspect.a034819"},{"issue":"1","key":"10.1016\/j.jare.2025.05.038_b0015","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41392-020-00361-x","article-title":"Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy","volume":"5","author":"Carter","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jare.2025.05.038_b0020","doi-asserted-by":"crossref","unstructured":"DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, Alteri R, Robbins AS, Jemal A: Cancer treatment and survivorship statistics, 201CA: a cancer journal for clinicians 2014, 64(4):252-271.","DOI":"10.3322\/caac.21235"},{"key":"10.1016\/j.jare.2025.05.038_b0025","first-page":"197","article-title":"Ara-C: cellular and molecular pharmacology","volume":"72","author":"Grant","year":"1998","journal-title":"Adv Cancer Res"},{"issue":"16","key":"10.1016\/j.jare.2025.05.038_b0030","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1080\/14656566.2017.1391216","article-title":"Cytarabine and daunorubicin for the treatment of acute myeloid leukemia","volume":"18","author":"Murphy","year":"2017","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"10.1016\/j.jare.2025.05.038_b0035","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1182\/blood.V98.4.913","article-title":"Signaling pathways activated by daunorubicin","volume":"98","author":"Laurent","year":"2001","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jare.2025.05.038_b0040","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1182\/blood.V58.6.1203.1203","article-title":"Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B","volume":"58","author":"Rai","year":"1981","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jare.2025.05.038_b0045","first-page":"485","article-title":"Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia","volume":"57","author":"Yates","year":"1973","journal-title":"Cancer Chemother Rep"},{"issue":"35","key":"10.1016\/j.jare.2025.05.038_b0050","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1038\/sj.onc.1205699","article-title":"5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy","volume":"21","author":"Christman","year":"2002","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.jare.2025.05.038_b0055","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s40265-016-0585-0","article-title":"Azacitidine: A review in myelodysplastic syndromes and acute myeloid leukaemia","volume":"76","author":"Scott","year":"2016","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.jare.2025.05.038_b0060","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ijc.23607","article-title":"Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine","volume":"123","author":"Stresemann","year":"2008","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.jare.2025.05.038_b0065","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00277-018-3304-y","article-title":"Salvage regimens using conventional chemotherapy agents for relapsed\/refractory adult AML patients: a systematic literature review","volume":"97","author":"Meg\u00edas-Vericat","year":"2018","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.jare.2025.05.038_b0070","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.stem.2014.02.006","article-title":"Evolution of the cancer stem cell model","volume":"14","author":"Kreso","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"7","key":"10.1016\/j.jare.2025.05.038_b0075","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/nm.4125","article-title":"Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia","volume":"22","author":"Li","year":"2016","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.jare.2025.05.038_b0080","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1038\/s41467-017-01834-4","article-title":"The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemia","volume":"8","author":"Di Tullio","year":"2017","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.jare.2025.05.038_b0085","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.3324\/haematol.2019.226282","article-title":"Plasticity in growth behavior of patients' acute myeloid leukemia stem cells growing in mice","volume":"105","author":"Ebinger","year":"2020","journal-title":"Haematologica"},{"issue":"33","key":"10.1016\/j.jare.2025.05.038_b0090","doi-asserted-by":"crossref","first-page":"20117","DOI":"10.1073\/pnas.2003900117","article-title":"Multidimensional study of the heterogeneity of leukemia cells in t(8;21) acute myelogenous leukemia identifies the subtype with poor outcome","volume":"117","author":"Jiang","year":"2020","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.jare.2025.05.038_b0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13059-020-1936-4","article-title":"A post-transcriptional program of chemoresistance by AU-rich elements and TTP in quiescent leukemic cells","volume":"21","author":"Lee","year":"2020","journal-title":"Genome Biol"},{"key":"10.1016\/j.jare.2025.05.038_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2021.100850","article-title":"Hematopoietic versus leukemic stem cell quiescence: Challenges and therapeutic opportunities","volume":"50","author":"O'Reilly","year":"2021","journal-title":"Blood Rev"},{"issue":"1","key":"10.1016\/j.jare.2025.05.038_b0105","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1158\/2643-3230.BCD-21-0050","article-title":"Genetic and transcriptional contributions to relapse in normal karyotype acute myeloid leukemia","volume":"3","author":"Petti","year":"2022","journal-title":"Blood Cancer Discovery"},{"issue":"6","key":"10.1016\/j.jare.2025.05.038_b0110","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1158\/2159-8290.CD-20-1375","article-title":"Chemotherapy induces senescence-like resilient cells capable of initiating AML recurrence","volume":"11","author":"Duy","year":"2021","journal-title":"Cancer Discov"},{"issue":"7","key":"10.1016\/j.jare.2025.05.038_b0115","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","article-title":"Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism","volume":"7","author":"Farge","year":"2017","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.jare.2025.05.038_b0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12964-020-00627-5","article-title":"Drug resistance and cancer stem cells","volume":"19","author":"Li","year":"2021","journal-title":"Cell Commun Signal"},{"issue":"1","key":"10.1016\/j.jare.2025.05.038_b0125","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","article-title":"Cancer epigenetics: from mechanism to therapy","volume":"150","author":"Dawson","year":"2012","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.jare.2025.05.038_b0130","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrg.2016.13","article-title":"Epigenetic modulators, modifiers and mediators in cancer aetiology and progression","volume":"17","author":"Feinberg","year":"2016","journal-title":"Nat Rev Genet"},{"issue":"11","key":"10.1016\/j.jare.2025.05.038_b0135","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/s41588-020-00726-6","article-title":"Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity","volume":"52","author":"Kinker","year":"2020","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.jare.2025.05.038_b0140","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1158\/2159-8290.CD-19-0710","article-title":"Monocytic subclones confer resistance to venetoclax-based therapy in patients with acute myeloid leukemia","volume":"10","author":"Pei","year":"2020","journal-title":"Cancer Discov"},{"issue":"5","key":"10.1016\/j.jare.2025.05.038_b0145","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nmeth.1315","article-title":"mRNA-Seq whole-transcriptome analysis of a single cell","volume":"6","author":"Tang","year":"2009","journal-title":"Nat Methods"},{"issue":"6","key":"10.1016\/j.jare.2025.05.038_b0150","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","article-title":"Single-cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity","volume":"176","author":"van Galen","year":"2019","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.jare.2025.05.038_b0155","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s00018-022-04482-0","article-title":"Sample-multiplexing approaches for single-cell sequencing","volume":"79","author":"Zhang","year":"2022","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"10.1016\/j.jare.2025.05.038_b0160","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41375-022-01789-6","article-title":"Single-cell analysis reveals the chemotherapy-induced cellular reprogramming and novel therapeutic targets in relapsed\/refractory acute myeloid leukemia","volume":"37","author":"Li","year":"2023","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.jare.2025.05.038_b0165","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.jare.2025.05.038_b0170","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jare.2025.05.038_b0175","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1158\/2159-8290.CD-21-0316","article-title":"Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level","volume":"12","author":"Wu","year":"2022","journal-title":"Cancer Discov"},{"issue":"2","key":"10.1016\/j.jare.2025.05.038_b0180","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab579","article-title":"Accurate and fast cell marker gene identification with COSG","volume":"23","author":"Dai","year":"2022","journal-title":"Brief Bioinform"},{"issue":"12","key":"10.1016\/j.jare.2025.05.038_b0185","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/s41587-020-0591-3","article-title":"Generalizing RNA velocity to transient cell states through dynamical modeling","volume":"38","author":"Bergen","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"6476","key":"10.1016\/j.jare.2025.05.038_b0190","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.aax0249","article-title":"Single-cell transcriptional diversity is a hallmark of developmental potential","volume":"367","author":"Gulati","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jare.2025.05.038_b0195","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41421-020-00223-4","article-title":"Integrated decoding hematopoiesis and leukemogenesis using single-cell sequencing and its medical implication","volume":"7","author":"Qin","year":"2021","journal-title":"Cell Discovery"},{"issue":"1","key":"10.1016\/j.jare.2025.05.038_b0200","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41392-020-00222-7","article-title":"FGF\/FGFR signaling in health and disease","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jare.2025.05.038_b0205","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/biom10030487","article-title":"TGF-\u03b2 signaling","volume":"10","author":"Tzavlaki","year":"2020","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.jare.2025.05.038_b0210","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s13059-018-1603-1","article-title":"Cell Hashing with barcoded antibodies enables multiplexing and doublet detection for single cell genomics","volume":"19","author":"Stoeckius","year":"2018","journal-title":"Genome Biol"},{"key":"10.1016\/j.jare.2025.05.038_b0215","article-title":"Multiplexed single-cell RNA-seq via transient barcoding for simultaneous expression profiling of various drug perturbations","volume":"5(5):eaav2249","author":"Shin","year":"2019","journal-title":"Sci Adv"},{"issue":"2","key":"10.1016\/j.jare.2025.05.038_b0220","first-page":"1825","article-title":"Elevated expression of the MYB proto-oncogene like 2 (MYBL2)-encoding gene as a prognostic and predictive biomarker in human cancers","volume":"19","author":"Xin","year":"2022","journal-title":"Math Biosci Eng: MBE"},{"issue":"18","key":"10.1016\/j.jare.2025.05.038_b0225","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1182\/blood.2019000802","article-title":"circMYBL2, a circRNA from MYBL2, regulates FLT3 translation by recruiting PTBP1 to promote FLT3-ITD AML progression","volume":"134","author":"Sun","year":"2019","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.jare.2025.05.038_b0230","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2018100926","article-title":"Human GBP1 is a microbe-specific gatekeeper of macrophage apoptosis and pyroptosis","volume":"38","author":"Fisch","year":"2019","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.jare.2025.05.038_b0235","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1186\/s12951-022-01663-8","article-title":"Ferroptosis assassinates tumor","volume":"20","author":"Luo","year":"2022","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.jare.2025.05.038_b0240","article-title":"High expression level of the FTH1 gene is associated with poor prognosis in children with non-M3 acute myeloid leukemia","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"issue":"54","key":"10.1016\/j.jare.2025.05.038_b0245","doi-asserted-by":"crossref","first-page":"91979","DOI":"10.18632\/oncotarget.20559","article-title":"High bone marrow ID2 expression predicts poor chemotherapy response and prognosis in acute myeloid leukemia","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.jare.2025.05.038_b0250","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1158\/2159-8290.CD-19-1008","article-title":"Extracellular ATP and CD39 activate cAMP-mediated mitochondrial stress response to promote cytarabine resistance in acute myeloid leukemia","volume":"10","author":"Aroua","year":"2020","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.jare.2025.05.038_b0255","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ccell.2019.06.003","article-title":"Mubritinib targets the electron transport chain complex i and reveals the landscape of OXPHOS dependency in acute myeloid leukemia","volume":"36","author":"Baccelli","year":"2019","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.jare.2025.05.038_b0260","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41590-020-0758-6","article-title":"The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation","volume":"21","author":"Ng","year":"2020","journal-title":"Nat Immunol"},{"issue":"26","key":"10.1016\/j.jare.2025.05.038_b0265","doi-asserted-by":"crossref","first-page":"5930","DOI":"10.1182\/blood-2010-01-262006","article-title":"A mechanistic rationale for combining alemtuzumab and rituximab in the treatment of ALL","volume":"116","author":"Nijmeijer","year":"2010","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jare.2025.05.038_b0270","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41419-021-04140-6","article-title":"EMP3 negatively modulates breast cancer cell DNA replication, DNA damage repair, and stem-like properties","volume":"12","author":"Zhou","year":"2021","journal-title":"Cell Death Dis"},{"issue":"11","key":"10.1016\/j.jare.2025.05.038_b0275","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.52586\/5018","article-title":"Identification of candidate biomarker EMP3 and its prognostic potential in clear cell renal cell carcinoma","volume":"26","author":"Lv","year":"2021","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"2","key":"10.1016\/j.jare.2025.05.038_b0280","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.3892\/ol.2020.11718","article-title":"HLX affects cell cycle and proliferation in AML cells via the JAK\/STAT signaling pathway","volume":"20","author":"Zhu","year":"2020","journal-title":"Oncol Lett"},{"issue":"2","key":"10.1016\/j.jare.2025.05.038_b0285","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ccr.2012.06.027","article-title":"H2.0-like homeobox regulates early hematopoiesis and promotes acute myeloid leukemia","volume":"22","author":"Kawahara","year":"2012","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.jare.2025.05.038_b0290","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1038\/s41467-018-05311-4","article-title":"A metabolic interplay coordinated by HLX regulates myeloid differentiation and AML through partly overlapping pathways","volume":"9","author":"Piragyte","year":"2018","journal-title":"Nat Commun"},{"issue":"17","key":"10.1016\/j.jare.2025.05.038_b0295","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.21037\/atm-21-3641","article-title":"Key immune-related gene ITGB2 as a prognostic signature for acute myeloid leukemia","volume":"9","author":"Wei","year":"2021","journal-title":"Ann Translational Med"},{"issue":"13","key":"10.1016\/j.jare.2025.05.038_b0300","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1016\/j.febslet.2005.04.011","article-title":"NMR structure and regulated expression in APL cell of human SH3BGRL3","volume":"579","author":"Xu","year":"2005","journal-title":"FEBS Lett"},{"issue":"9","key":"10.1016\/j.jare.2025.05.038_b0305","doi-asserted-by":"crossref","DOI":"10.3390\/biom9090505","article-title":"Elevated SH3BP5 correlates with poor outcome and contributes to the growth of acute myeloid leukemia cells","volume":"9","author":"Li","year":"2019","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.jare.2025.05.038_b0310","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1073\/pnas.1813666116","article-title":"Multiomics of azacitidine-treated AML cells reveals variable and convergent targets that remodel the cell-surface proteome","volume":"116","author":"Leung","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jare.2025.05.038_b0315","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40364-018-0149-4","article-title":"The orphan nuclear receptor EAR-2 (NR2F6) inhibits hematopoietic cell differentiation and induces myeloid dysplasia in vivo","volume":"6","author":"Ichim","year":"2018","journal-title":"Biomarker Res"},{"issue":"11","key":"10.1016\/j.jare.2025.05.038_b0320","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/leu.2011.137","article-title":"Identification of a role for the nuclear receptor EAR-2 in the maintenance of clonogenic status within the leukemia cell hierarchy","volume":"25","author":"Ichim","year":"2011","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.jare.2025.05.038_b0325","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.devcel.2020.11.012","article-title":"Centrosomal localization of RXR\u03b1 promotes PLK1 activation and mitotic progression and constitutes a tumor vulnerability","volume":"55","author":"Xie","year":"2020","journal-title":"Dev Cell"},{"issue":"562","key":"10.1016\/j.jare.2025.05.038_b0330","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aau9048","article-title":"GPR35 promotes glycolysis, proliferation, and oncogenic signaling by engaging with the sodium potassium pump","volume":"12","author":"Schneditz","year":"2019","journal-title":"Sci Signal"},{"issue":"6","key":"10.1016\/j.jare.2025.05.038_b0335","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41388-021-02123-7","article-title":"Pharmacological inhibition of LSD1 triggers myeloid differentiation by targeting GSE1 oncogenic functions in AML","volume":"41","author":"Nicosia","year":"2022","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.jare.2025.05.038_b0340","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/s12935-021-02123-3","article-title":"Emerging roles of a pivotal lncRNA SBF2-AS1 in cancers","volume":"21","author":"Lu","year":"2021","journal-title":"Cancer Cell Int"},{"issue":"4","key":"10.1016\/j.jare.2025.05.038_b0345","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","article-title":"Clonal heterogeneity and tumor evolution: past, present, and the future","volume":"168","author":"McGranahan","year":"2017","journal-title":"Cell"},{"issue":"7382","key":"10.1016\/j.jare.2025.05.038_b0350","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature10738","article-title":"Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing","volume":"481","author":"Ding","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jare.2025.05.038_b0355","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2018-08-868752","article-title":"Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia","volume":"133","author":"DiNardo","year":"2019","journal-title":"Blood"},{"issue":"7954","key":"10.1016\/j.jare.2025.05.038_b0360","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/s41586-023-05812-3","article-title":"The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia","volume":"615","author":"Issa","year":"2023","journal-title":"Nature"},{"issue":"8012","key":"10.1016\/j.jare.2025.05.038_b0365","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-024-07328-w","article-title":"Transient loss of Polycomb components induces an epigenetic cancer fate","volume":"629","author":"Parreno","year":"2024","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.jare.2025.05.038_b0370","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1182\/blood-2014-10-605808","article-title":"Secondary mutations as mediators of resistance to targeted therapy in leukemia","volume":"125","author":"Daver","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jare.2025.05.038_b0375","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10585-022-10189-0","article-title":"Resistance to targeted therapies in acute myeloid leukemia","volume":"40","author":"Mecklenbrauck","year":"2023","journal-title":"Clin Exp Metastasis"},{"issue":"12","key":"10.1016\/j.jare.2025.05.038_b0380","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1158\/2159-8290.CD-18-0877","article-title":"Isoform switching as a mechanism of acquired resistance to mutant isocitrate dehydrogenase inhibition","volume":"8","author":"Harding","year":"2018","journal-title":"Cancer Discov"},{"issue":"19","key":"10.1016\/j.jare.2025.05.038_b0385","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/blood.2023023644","article-title":"Epigenetic regulation of noncanonical menin targets modulates menin inhibitor response in acute myeloid leukemia","volume":"144","author":"Zhou","year":"2024","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jare.2025.05.038_b0390","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1038\/s41467-025-58370-9","article-title":"Epigenetic mechanisms controlling human leukemia stem cells and therapy resistance","volume":"16","author":"Takao","year":"2025","journal-title":"Nat Commun"},{"issue":"24","key":"10.1016\/j.jare.2025.05.038_b0395","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1182\/blood-2008-05-158311","article-title":"Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML","volume":"113","author":"Zeng","year":"2009","journal-title":"Blood"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225003583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225003583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T01:49:05Z","timestamp":1769824145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123225003583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":79,"alternative-id":["S2090123225003583"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2025.05.038","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dynamic heterogeneity towards drug resistance in AML cells is primarily driven by epigenomic mechanism unveiled by multi-omics analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2025.05.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}